We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-5.84%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$5.99B
AUM Growth
-$571M
Cap. Flow
-$107M
Cap. Flow %
-1.78%
Top 10 Hldgs %
12.64%
Holding
363
New
17
Increased
100
Reduced
214
Closed
10

Top Buys

Rank Stock Value
1
ACH
Accendra Health
ACH
+$32.5M
2
CHE icon
Chemed
CHE
+$26.3M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.6M
4
OII icon
Oceaneering
OII
+$14.8M
5
EV
Eaton Vance Corp.
EV
+$14.2M

Top Sells

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$39.6M
2
THOR
THORATEC CORPORATION
THOR
+$27.6M
3
DTV
DIRECTV COM STK (DE)
DTV
+$26M
4
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$24M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.1M

Sector Composition

Rank Sector Weight
1 Financials 17.98%
2 Technology 15.56%
3 Healthcare 15.35%
4 Industrials 12.45%
5 Consumer Discretionary 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZO icon
276
AutoZone
AZO
$50.9B
$1.38M 0.02%
1,900
-400
-17% -$283K
NTAP icon
277
NetApp
NTAP
$34.2B
$1.32M 0.02%
44,725
+2,575
+6% +$79.4K
CSL icon
278
Carlisle Companies
CSL
$14.1B
$1.29M 0.02%
14,825
-6,050
-29% -$605K
BEN icon
279
Franklin Resources
BEN
$17.3B
$1.29M 0.02%
34,557
+20,361
+143% +$881K
EWJ icon
280
iShares MSCI Japan ETF
EWJ
$21.3B
$1.29M 0.02%
28,150
+325
+1% +$16K
ABBV icon
281
AbbVie
ABBV
$465B
$1.25M 0.02%
23,055
+663
+3% +$43.2K
EGN
282
DELISTED
Energen
EGN
$1.24M 0.02%
24,780
+1,530
+7% +$82.5K
EG icon
283
Everest Group
EG
$15.8B
$1.19M 0.02%
6,875
-1,275
-16% -$231K
BMY icon
284
Bristol-Myers Squibb
BMY
$130B
$1.13M 0.02%
19,129
-565
-3% -$35.8K
SON icon
285
Sonoco
SON
$5.99B
$1.09M 0.02%
28,987
-5,925
-17% -$241K
DGX icon
286
Quest Diagnostics
DGX
$26B
$1.09M 0.02%
17,770
-3,600
-17% -$252K
VZ icon
287
Verizon
VZ
$201B
$1.03M 0.02%
23,591
+2,134
+10% +$98.5K
WDC icon
288
Western Digital
WDC
$160B
$1.01M 0.02%
16,901
-3,420
-17% -$206K
GEN icon
289
Gen Digital
GEN
$16.5B
$981K 0.02%
50,400
-10,075
-17% -$217K
ESND
290
DELISTED
Essendant Inc.
ESND
$955K 0.02%
29,450
-5,750
-16% -$204K
TECD
291
DELISTED
Tech Data Corp
TECD
$935K 0.02%
13,650
-2,800
-17% -$171K
LOW icon
292
Lowe's Companies
LOW
$122B
$902K 0.02%
13,093
– –
TGT icon
293
Target
TGT
$65.5B
$871K 0.01%
11,078
– –
APH icon
294
Amphenol
APH
$177B
$849K 0.01%
66,640
+220
+0.3% +$2.95K
KSS icon
295
Kohl's
KSS
$2.16B
$837K 0.01%
18,075
-3,850
-18% -$217K
CELG
296
DELISTED
Celgene Corp
CELG
$837K 0.01%
7,741
-1,279
-14% -$159K
BIIB icon
297
Biogen
BIIB
$30.4B
$836K 0.01%
2,865
+400
+16% +$132K
EPP icon
298
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
$832K 0.01%
22,700
+400
+2% +$16K
K
299
DELISTED
Kellanova
K
$814K 0.01%
13,020
-106
-0.8% -$6.61K
VEU icon
300
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$803K 0.01%
18,825
-4,128
-18% -$191K
10 11
12
13 14

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Trust Walden held 363 positions worth $5.99B, down 8.7% from $6.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Trust Walden's Q3 2015 filing shows 17 new, 100 increased, 214 reduced and 10 closed positions. Its largest new stake was Accendra Health: 954,271 shares worth $30.5M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $39.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q3 2015 buy was Accendra Health: 954,271 shares worth $30.5M.
  • Boston Trust Walden added most to Oceaneering in Q3 2015, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $19.1M.
  • Boston Trust Walden fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $39.6M.
  • Boston Trust Walden's ten largest holdings make up 13% of its $5.99B portfolio in Q3 2015.
  • Boston Trust Walden opened 17 new positions and closed 10 in Q3 2015.
  • Boston Trust Walden's portfolio value fell 8.7% quarter-over-quarter to $5.99B.

Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.